Harriet Mayanja-Kizza
Overview
Explore the profile of Harriet Mayanja-Kizza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
4527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ssebuliba M, Ssinabulya I, Sebatta E, Mayanja-Kizza H, Lugero C
Cureus
. 2025 Jan;
16(12):e75578.
PMID: 39803051
Acute coronary syndrome is the leading cause of death worldwide, with the highest rates occurring in low-income global regions. This is possibly due to increasing levels of urbanization, which are...
2.
Dill-McFarland K, Simmons J, Peterson G, Nguyen F, Campo M, Benchek P, et al.
mSystems
. 2024 Aug;
9(9):e0062824.
PMID: 39162406
(Mtb) exposure leads to a range of outcomes including clearance, latent TB infection (LTBI), and pulmonary tuberculosis (TB). Some heavily exposed individuals resist tuberculin skin test (TST) and interferon-gamma (IFNγ)...
3.
Sun M, Phan J, Kieswetter N, Huang H, Yu K, Smith M, et al.
Nat Immunol
. 2024 Aug;
25(10):1976.
PMID: 39160374
No abstract available.
4.
Cirillo D, Anthony R, Gagneux S, Horsburgh Jr C, Hasan R, Darboe S, et al.
Lancet Glob Health
. 2024 Jul;
12(8):e1225-e1226.
PMID: 39030054
No abstract available.
5.
Sun M, Phan J, Kieswetter N, Huang H, Yu K, Smith M, et al.
Nat Immunol
. 2024 Jul;
25(8):1411-1421.
PMID: 38997431
A subset of individuals exposed to Mycobacterium tuberculosis (Mtb) that we refer to as 'resisters' (RSTR) show evidence of IFN-γ T cell responses to Mtb-specific antigens despite serially negative results...
6.
Okello C, Shih A, Nabwana M, Kiwanuka N, Heddle N, Mayanja-Kizza H, et al.
Afr Health Sci
. 2024 Jul;
23(4):362-370.
PMID: 38974296
Background: There is limited data on red blood cell (RBC) alloimmunization in patients with cancer in sub-Saharan Africa (SSA). We examined the frequency of RBC alloimmunization in transfused patients with...
7.
Kayongo A, Ntayi M, Olweny G, Kyalo E, Ndawula J, Ssengooba W, et al.
iScience
. 2024 Jun;
27(6):110142.
PMID: 38904070
remains one of the deadliest infectious agents globally. Amidst efforts to control TB, long treatment duration, drug toxicity, and resistance underscore the need for novel therapeutic strategies. Despite advances in...
8.
Okello C, Orem J, Nabwana M, Kiwanuka N, Shih A, Heddle N, et al.
BMC Cancer
. 2024 Jun;
24(1):677.
PMID: 38831291
Background: Mortality benefit of transfusion with leucoreduced whole blood has not been demonstrated in the sub-Saharan Africa (SSA). We compared mortality in patients with cancer transfused with leucoreduced and non-leucoreduced...
9.
Cross D, Layton E, Yu K, Smith M, Aguilar M, Li S, et al.
JCI Insight
. 2024 May;
9(9).
PMID: 38716731
T cells are required for protective immunity against Mycobacterium tuberculosis. We recently described a cohort of Ugandan household contacts of tuberculosis cases who appear to "resist" M. tuberculosis infection (resisters;...
10.
Gutierrez J, Nsereko M, Malone L, Mayanja-Kizza H, Kisingo H, Boom W, et al.
Trop Med Infect Dis
. 2024 Apr;
9(4).
PMID: 38668542
Reductions in tuberculosis (TB) incidence require identification of individuals at high risk of developing active disease, such as those with recent () infection. Using a prospective household contact (HHC) study...